22 May 2013
Keywords: zofran, study, results, glaxo, ondansetron, plus, dopamine
Article | 26 April 1993
- Glaxo's Zofran (ondansetron) plus the dopamine antagonist
metopimazine was a highly effective and safe antiemetic therapy that is
markedly superior ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
26 April 1993
3 May 1993
21 May 2013
© 2013 thepharmaletter.com